Atlas Trials

Addition of Opaganib to Androgen Antagonists in Patients With mCRPC

Clinical trial NCT04207255 · COMPLETED

Trial details

NCT number
NCT04207255
Sponsor
Medical University of South Carolina
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2020-03-27
Primary completion
2023-08-31
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.